Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment
Abstract
Share and Cite
Shapoval, O.; Patsula, V.; Větvička, D.; Šlouf, M.; Kabešová, M.; Vasylyshyn, T.; Svobodová, L.M.; Konefal, M.; Kočková, O.; Pankrác, J.; et al. Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment. Nanomaterials 2025, 15, 1690. https://doi.org/10.3390/nano15221690
Shapoval O, Patsula V, Větvička D, Šlouf M, Kabešová M, Vasylyshyn T, Svobodová LM, Konefal M, Kočková O, Pankrác J, et al. Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment. Nanomaterials. 2025; 15(22):1690. https://doi.org/10.3390/nano15221690
Chicago/Turabian StyleShapoval, Oleksandr, Vitalii Patsula, David Větvička, Miroslav Šlouf, Martina Kabešová, Taras Vasylyshyn, Ludmila Maffei Svobodová, Magdalena Konefal, Olga Kočková, Jan Pankrác, and et al. 2025. "Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment" Nanomaterials 15, no. 22: 1690. https://doi.org/10.3390/nano15221690
APA StyleShapoval, O., Patsula, V., Větvička, D., Šlouf, M., Kabešová, M., Vasylyshyn, T., Svobodová, L. M., Konefal, M., Kočková, O., Pankrác, J., Matouš, P., Herynek, V., & Horák, D. (2025). Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment. Nanomaterials, 15(22), 1690. https://doi.org/10.3390/nano15221690

